Skip to main content
OpenTrials

Clinical trial condition

Extrahepatic Bile Duct Adenocarcinoma

Explore clinical trials studying Extrahepatic Bile Duct Adenocarcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Extrahepatic Bile Duct Adenocarcinoma trial results

Completed

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

NCT01093222

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +22 more
Locations
  • The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Fremont - Rideout Cancer Center Marysville, California, United States
View all 141 locations
View Trial Details

Related conditions